Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT Plus PEN as First-line Treatment in Active Pediatric Crohn's Disease
NCT05321758Recruiting
- Sponsor
- Tongji Hospital
- Start
- Mar 2020
- Primary completion
- Jun 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label trial of Fecal Microbiota Transplantation Capsule in Crohn's disease (2 arms), sponsored by Tongji Hospital. Primary endpoints: Clinical remission, Endoscopic remission and 1 more. Started Mar 2020; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT05321758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05321758.